Stolberg, Germany

Anja Geissler

This inventor holds 4 USPTO granted patents and 12 published patent applications, plus 3 CIPO patents and 6 EPO patents. Top assignees: Grunenthal Gmbh, Gruenenthal Gmbh. Active years: 2012-2019.

USPTO Granted Patents = 4 

% Patents Active = 75.0

 

 

Average Co-Inventor Count = 5.1

ph-index = 1

Forward Citations = 15(Granted Patents)


Location History:

  • Stolberg/Vicht, DE (2012)
  • Stolberg, DE (2018 - 2019)

Company Filing History:


Years Active: 2012-2019

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Anja Geissler: Innovator in Pharmaceutical Dosage Forms

Introduction

Anja Geissler is a prominent inventor based in Stolberg, Germany. She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative dosage forms. With a total of three patents to her name, her work is recognized for its impact on drug delivery systems.

Latest Patents

Among her latest patents is the "Oxidation-stabilized tamper-resistant dosage form," which features a thermoformed pharmaceutical dosage form with a breaking strength of at least 300 N. This innovative dosage form is designed to enhance the safety and efficacy of pharmaceutical products.

Career Highlights

Anja Geissler has established herself as a key figure in her field, working with Grunenthal GmbH, a company known for its commitment to developing effective pain management solutions. Her expertise in pharmaceutical formulations has been instrumental in advancing the company's product offerings.

Collaborations

Anja has collaborated with notable colleagues, including Lutz Barnscheid and Eric Galia, to further enhance the research and development of pharmaceutical innovations.

Conclusion

Anja Geissler's contributions to the pharmaceutical industry through her innovative patents and collaborative efforts highlight her role as a leading inventor in the field. Her work continues to influence the development of safer and more effective drug delivery systems.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…